➡️With the development of retzatapopt, combination therapies should be explored for those with MBC & TP53 Y220C alterations
#bcsm

📰 The Guardant360 CDx has received EU approval as a companion diagnostic to identify patients with ER+, HER2– locally advanced or metastatic breast cancer who may benefit from camizestrant. #bcsm #oncology

Full story ➡️: www.onclive.com/view/guardan...

"Practical, balanced, and written in a clear and non-technical style, helping readers navigate treatment decisions and make informed choices.” Jennifer M. Jones, PhD, University Health Network
Learn more about this title: https://bit.ly/4fg7xGD
The National Breast Cancer Coalition #BCSM

Great to be back in Chicago for the 2026 Fall Group Meeting @swog.org working alongside amazing patient advocates! #SWOGonco #oncoalert #bcam #breastcancer #breastcanceractionmonth #clinicaltrials #research #bcsm #cancer #healthequityforall #advocacy

#bcsm #bcam #breastcanceractionmonth #densebreasts #clinicaltrials #healthequityforall #research @swog.org @acscan.bsky.social @oncoalert.bsky.social

Following its May 2026 FDA approval, Dato-DXd has been approved in China for first-line metastatic TNBC ineligible for PD-1/PD-L1 inhibitor therapy #bcsm #oncology

www.onclive.com/view/china-s...

📰 China’s NMPA approved adjuvant T-DXd for HER2+ early breast cancer and residual invasive disease following neoadjuvant therapy with a taxane and trastuzumab. #bcsm #oncology

Full story ➡️: www.onclive.com/view/china-s...

September breast cancer news brought data, approvals, and plenty of expert perspectives. @danafarber.bsky.social @harvardmed.bsky.social @clevelandclinic.bsky.social #BreastCancerBriefing #oncology

Sign up to read a recap of the #bcsm news & insights we reported ➡️: www.onclive.com/view/breast-...

Did you miss any of September's pivotal @fda.gov oncology approvals? Catch up here with the data and significance of each decision #bcsm #lcsm #oncology

Read more: www.onclive.com/view/septemb...

🚨 BREAKING 🚨: The @fda.gov approved maintenance tucatinib plus trastuzumab and pertuzumab for unresectable locally advanced or metastatic HER2-positive breast cancer following induction treatment. #bcsm #oncology

Full story ➡️: www.onclive.com/view/fda-app...

WATCH 🎥: Alexis Ann LeVee, MD, previews the lidERA Breast Cancer PRO data being presented at the 2026 ESMO Congress. @myesmo.bsky.social #ESMO2026 #bcsm #oncology

Sign up to read the full preview ➡️: www.onclive.com/view/breast-...

WATCH 🎥: @kalinskykevin.bsky.social, of @winshipcancer.emory.edu, discusses key breast cancer abstracts being presented at the 2026 ESMO Congress. @myesmo.bsky.social #ESMO2026 #bcsm #oncology

Sign up to read our preview article for more insights ➡️: www.onclive.com/view/breast-...

Last week's #OncFive:

✅ Pirtobrutinib OK'd in 1L CLL/SLL #lymsm #leusm
🎗️ Priority review: elinzanetant for breast cancer #bcsm
🩸 Tabelecleucel BLA resubmitted in EBV+ PTLD
🫁 Savolitinib+osimertinib NDA in MET+ NSCLC #lcsm
🫁 Zipalertinib NDA starts in NSCLC

🔗: www.onclive.com/view/the-onc...

Five facts explain why male #breastcancer happens and what changes its outcome. They involve where the first sign shows up, how the disease runs in families, what raises risk and why treatment still borrows from research on women.

#nenshealth #bcsm #hereditarycancer #BRCA

Did you miss key updates in NSCLC, breast cancer, MDS, and PTLD? Test your knowledge with this week's OncLive news quiz #lcsm #bcsm #mpnsm #oncology

www.onclive.com/view/onclive...

lobularbreastcancer.org/lbca-research-grantee-interview-exploring-what-drives-ilc-metastasis/ #bcsm, #lobularbreastcan #ILC, #lobular, #ILCAwareness, #learnaboutlobular
Christina Curtis & Deborah Rohmer: Important new ILC research and "how to's of good advocacy".

If you saw the study saying GLP1s have an outlandish effect on breast cancer survival and recurrence based on electronic medical records, and were underwhelmed, this study took a different approach, addressing prevention 🧪 CanSky OncoSky #breastcancer #BCSM #ThinkPink #KnowYourRisk

Breast cancer Tx can have lasting effects on CV health, making heart care essential to survivorship. This #BreastCancerAwarenessMonth, explore how #JACCCardioOnc advances cancer & CV care through research, expert perspectives & clinical insights. https://bit.ly/3ThPZmG #BreastCancerAwareness #BCsm

👀 Looking ahead to the 2026 ESMO Congress? See which breast cancer presentations @kalinskykevin.bsky.social, of @winshipcancer.emory.edu, and Alexis Ann LeVee, MD, are most looking forward to. @myesmo.bsky.social #bcsm #oncology

Sign up to read the full preview ➡️: www.onclive.com/view/breast-...

🧬 Researchers at @wakeforestmed.bsky.social identified a protein that may help breast cancer spread to the brain and evade immune defenses. #bcsm #oncology

Read more ➡️: www.onclive.com/view/researc...